| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
57,811,000 |
| Market
Cap: |
593.72(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$10.13 - $30.69 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : 5.2 |
| Insider 6 Months : 5.2 |
| Insider 3/6 Months : 10.8 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Embecta is global medical device company focused on providing solutions to improve the health and wellbeing of people living with diabetes. Co. has a portfolio of marketed products, including various of pen needles, syringes and safety devices, which are complemented by its proprietary digital applications. Co.'s pen needles are sterile, single-use, medical devices, designed to be used in conjunction with insulin pens and are used to inject insulin or other diabetes medications. Co. also sells safety pen needles, which include resin injection-molded shields on both ends of the cannula that automatically deploy to help prevent needlestick exposure and injury during injection and disposal.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
2,000 |
2,000 |
22,558 |
25,658 |
| Total Buy Value |
$32,500 |
$32,500 |
$441,865 |
$542,646 |
| Total People Bought |
1 |
1 |
4 |
4 |
| Total Buy Transactions |
1 |
1 |
5 |
6 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Kurdikar Devdatt |
President and CEO |
• • – |
2023-08-10 |
4 |
B |
$21.81 |
$109,050 |
D/D |
5,000 |
244,791 |
2.81 |
-16% |
|
| Casner Jean |
Chief Human Resources Officer |
• – – |
2023-08-09 |
4 |
A |
$0.00 |
$0 |
D/D |
11,277 |
11,277 |
|
- |
|
| Elguicze Jacob |
SVP and CFO |
• – – |
2023-05-10 |
4 |
D |
$29.58 |
$29,225 |
D/D |
(988) |
61,402 |
|
- |
|
| Kurdikar Devdatt |
President and CEO |
• • – |
2023-04-04 |
4/A |
D |
$27.36 |
$124,078 |
D/D |
(4,535) |
239,791 |
|
- |
|
| Kurdikar Devdatt |
President and CEO |
• • – |
2023-04-04 |
4 |
D |
$27.36 |
$133,380 |
D/D |
(4,875) |
239,451 |
|
- |
|
| Melcher David F |
Director |
– • – |
2023-02-15 |
4 |
B |
$32.51 |
$100,781 |
D/D |
3,100 |
21,465 |
2.39 |
-29% |
|
| Kurdikar Devdatt |
President and CEO |
• • – |
2023-02-11 |
4 |
D |
$28.51 |
$60,128 |
D/D |
(2,109) |
244,326 |
|
- |
|
| Anderson Carrie L |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
13,069 |
|
- |
|
| Hombach Robert J. |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
13,075 |
|
- |
|
| Morris Milton Mayo |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
13,069 |
|
- |
|
| Reidy Christopher R |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
20,555 |
|
- |
|
| Albritton David |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
13,069 |
|
- |
|
| Pomeroy Claire |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
14,632 |
|
- |
|
| Prange Karen |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,979 |
13,069 |
|
- |
|
| Melcher David F |
Director |
– • – |
2023-02-09 |
4 |
A |
$0.00 |
$0 |
D/D |
9,073 |
18,365 |
|
- |
|
| Curtis Shaun |
SVP, Global Manuf./Sup. Chain |
• – – |
2023-01-27 |
4 |
D |
$27.40 |
$25,208 |
D/D |
(920) |
26,103 |
|
- |
|
| Melcher David F |
Director |
– • – |
2022-12-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,954 |
9,214 |
|
- |
|
| Elguicze Jacob |
SVP and CFO |
• – – |
2022-11-26 |
4 |
D |
$33.04 |
$44,075 |
D/D |
(1,334) |
62,390 |
|
- |
|
| Elguicze Jacob |
SVP and CFO |
• – – |
2022-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
24,214 |
63,724 |
|
- |
|
| Mann Jeffrey Z |
SVP, GC, Head Corp. Dev., Secy |
• – – |
2022-11-26 |
4 |
D |
$33.04 |
$47,280 |
D/D |
(1,431) |
50,633 |
|
- |
|
| Mann Jeffrey Z |
SVP, GC, Head Corp. Dev., Secy |
• – – |
2022-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
19,674 |
52,064 |
|
- |
|
| Kumar Ajay |
SVP and CHRO |
• – – |
2022-11-26 |
4 |
D |
$33.04 |
$59,670 |
D/D |
(1,806) |
28,444 |
|
- |
|
| Kumar Ajay |
SVP and CHRO |
• – – |
2022-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
7,794 |
30,250 |
|
- |
|
| Curtis Shaun |
SVP, Global Manuf./Sup. Chain |
• – – |
2022-11-26 |
4 |
D |
$33.04 |
$72,391 |
D/D |
(2,191) |
27,023 |
|
- |
|
| Curtis Shaun |
SVP, Global Manuf./Sup. Chain |
• – – |
2022-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
9,080 |
29,214 |
|
- |
|
79 Records found
|
|
Page 2 of 4 |
|
|
0.28 (2.65%) 
